Taysha Gene Therapies (TSHA) PT Raised to $40 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Silvan Tuerkcan raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $40.00 (from $38.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
